» Articles » PMID: 34897289

Natural History of NF1 C.2970_2972del P.(Met992del): Confirmation of a Low Risk of Complications in a Longitudinal Study

Abstract

Individuals with the three base pair deletion NM_000267.3(NF1):c.2970_2972del p.(Met992del) have been recognised to present with a milder neurofibromatosis type 1 (NF1) phenotype characterised by café-au-lait macules (CALs) and intertriginous freckling, as well as a lack of cutaneous, subcutaneous and plexiform neurofibromas and other NF1-associated complications. Examining large cohorts of patients over time with this specific genotype is important to confirm the presentation and associated risks of this variant across the lifespan. Forty-one individuals with the in-frame NF1 deletion p.Met992del were identified from 31 families. Clinicians completed a standardised clinical questionnaire for each patient and the resulting data were collated and compared to published cohorts. Thirteen patients have been previously reported, and updated clinical information has been obtained for these individuals. Both CALs and intertriginous freckling were present in the majority of individuals (26/41, 63%) and the only confirmed features in 11 (27%). 34/41 (83%) of the cohort met NIH diagnostic criteria. There was a notable absence of all NF1-associated tumour types (neurofibroma and glioma). Neurofibroma were observed in only one individual-a subcutaneous lesion (confirmed histologically). Nineteen individuals were described as having a learning disability (46%). This study confirms that individuals with p.Met992del display a mild tumoural phenotype compared to those with 'classical', clinically diagnosed NF1, and this appears to be the case longitudinally through time as well as at presentation. Learning difficulties, however, appear to affect a significant proportion of NF1 subjects with this phenotype. Knowledge of this genotype-phenotype association is fundamental to accurate prognostication for families and caregivers.

Citing Articles

Pigment epithelium derived factor drives melanocyte proliferation and migration in neurofibromatosis café au lait macules.

Lovatt C, Williams M, Gibbs A, Mukhtar A, Morgan H, Lanfredini S Skin Health Dis. 2024; 4(5):e394.

PMID: 39355740 PMC: 11442068. DOI: 10.1002/ski2.394.


Genotype-Phenotype Correlation in Neurofibromatosis Type 1: Evidence for a Mild Phenotype Associated with Splicing Variants Leading to In-Frame Skipping of Exon 24 [19a].

Chen Y, Fu Y, Koczkowska M, Callens T, Gomes A, Liu J Cancers (Basel). 2024; 16(13).

PMID: 39001468 PMC: 11240586. DOI: 10.3390/cancers16132406.


Genotype-phenotype correlations and treatment innovation of neurofibromatosis type 1 (NF1): Current understanding and perspective.

Zhu B, Wang W, Gu Y, Wei C, Wang Z, Li Q Chin Med J (Engl). 2024; 137(14):1639-1641.

PMID: 38915235 PMC: 11268811. DOI: 10.1097/CM9.0000000000003203.


Genotype-phenotype correlations of neurofibromatosis type 1: a cross-sectional study from a large Chinese cohort.

Zhu B, Zheng T, Wang W, Gu Y, Wei C, Li Q J Neurol. 2023; 271(4):1893-1900.

PMID: 38095723 DOI: 10.1007/s00415-023-12127-w.


2022: the year that was in the European Journal of Human Genetics.

McNeill A Eur J Hum Genet. 2023; 31(2):131-133.

PMID: 36750730 PMC: 9905485. DOI: 10.1038/s41431-023-01283-2.


References
1.
Anastasaki C, Gao F, Gutmann D . Commentary: Identification of Mutation Regions on Responsible for High- and Low-Risk Development of Optic Pathway Glioma in Neurofibromatosis Type I. Front Genet. 2019; 10:115. PMC: 6405421. DOI: 10.3389/fgene.2019.00115. View

2.
Rojnueangnit K, Xie J, Gomes A, Sharp A, Callens T, Chen Y . High Incidence of Noonan Syndrome Features Including Short Stature and Pulmonic Stenosis in Patients carrying NF1 Missense Mutations Affecting p.Arg1809: Genotype-Phenotype Correlation. Hum Mutat. 2015; 36(11):1052-63. PMC: 5049609. DOI: 10.1002/humu.22832. View

3.
Ben-Shachar S, Constantini S, Hallevi H, Sach E, Upadhyaya M, Evans G . Increased rate of missense/in-frame mutations in individuals with NF1-related pulmonary stenosis: a novel genotype-phenotype correlation. Eur J Hum Genet. 2012; 21(5):535-9. PMC: 3641387. DOI: 10.1038/ejhg.2012.221. View

4.
Koczkowska M, Callens T, Chen Y, Gomes A, Hicks A, Sharp A . Clinical spectrum of individuals with pathogenic NF1 missense variants affecting p.Met1149, p.Arg1276, and p.Lys1423: genotype-phenotype study in neurofibromatosis type 1. Hum Mutat. 2019; 41(1):299-315. PMC: 6973139. DOI: 10.1002/humu.23929. View

5.
Pinna V, Lanari V, Daniele P, Consoli F, Agolini E, Margiotti K . p.Arg1809Cys substitution in neurofibromin is associated with a distinctive NF1 phenotype without neurofibromas. Eur J Hum Genet. 2014; 23(8):1068-71. PMC: 4795103. DOI: 10.1038/ejhg.2014.243. View